Overview

Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This study is a multi-center, open-label study of intravenous (IV) ANX005 in subjects with Amyotrophic Lateral Sclerosis ((ALS).
Phase:
Phase 2
Details
Lead Sponsor:
Annexon, Inc.
Collaborator:
Worldwide Clinical Trials